Tectonic Therapeutic Inc. Ordinary Shares TECX 深 滬
已收盤 09-05 16:00:00 美东时间
16.80
-0.470
-2.72%
華盛通- 最 高18.03
- 今 開17.30
- 成交量 68.37万股
- 最 低 16.72
- 昨 收 17.27
- 總市值 3.14亿
- 52周最高 61.07
- 市盈率 靜 --
- 換手率 3.66%
- 52周最低 13.70
- 委 比 -52.21%
- 總股本 1867.25万
- 歷史最高 644.40
- 量 比 0.63
- 振 幅 7.59%
- 歷史最低 6.72
- 每 手 1
- 風險率 10.96%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Canopy Growth, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were lower this morning, with the Dow futures falling around...
09-02 20:00
Tectonic Therapeutic to Participate in September Investor Conferences
Tectonic Therapeutic, a clinical-stage biotech company focused on therapeutic proteins and antibodies targeting GPCRs, announced that its management will participate in three investor conferences in September 2025. The events include the 2025 Wells Fargo Healthcare Conference in Boston on September 3, the Cantor Global Healthcare Conference in New York on September 4 featuring CFO Daniel Lochner and CBO Marc Schwabish, and the Morgan Stanley 23rd...
08-28 13:00
Tectonic Therapeutic shares are trading lower after the company reported worse-than-expected Q2 EPS results.
Tectonic Therapeutic shares are trading lower after the company reported worse-...
08-08 04:58
Tectonic Therapeutic joins Russell 3000 index
Tectonic Therapeutic (NASDAQ:TECX) has been added to the broad-market Russell 3000 Index as part of the 2025 Russell US Indexes annual reconstitution. The addition is effective after the open of US eq...
06-30 21:21
Tectonic Therapeutic Joins Russell 3000® Index
Tectonic Therapeutic, Inc. has been added to the Russell 3000® Index following the 2025 Russell US Indexes annual reconstitution. The change will take effect after the US equity market open on June 30, 2025. The Russell 3000 Index includes the 3,000 largest US stocks by market capitalization and encompasses both the Russell 1000 and Russell 2000 indexes. Tectonic, a clinical-stage biotech company focused on developing therapeutic proteins and ant...
06-30 12:00
美股大行评级 | GitLab遭多家大行下调目标价！Stifel首予优步"买入"评级，目标价110美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1139839943846023169.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Loop Capital：维持Dave & Buster's Enter(PLAY)"买入"评级，目标价从35美元升至46美元</p> <p>• Stifel：维持嘉年华(CCL)"买入"评级，目标价从31美元升至
06-12 09:46
Raymond James Reinstates Outperform on Tectonic Therapeutic, Announces $76 Price Target
Raymond James analyst Michael Freeman reinstates Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and announces $76 price target.
06-12 00:32
Tectonic Therapeutics shares are trading higher after the company announced it presented full Phase 1b results for TX45.
Tectonic Therapeutics shares are trading higher after the company announced it ...
05-20 00:16
